Related Experiment Video
Updated: Jun 6, 2026
08:32
Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice
Published on: March 10, 2017
Serum prohepcidin levels in chronic inflammatory bowel diseases
Judit Nagy1, Lilla Lakner, Viktor S Poór
1Institute of Laboratory Medicine, Faculty of Medicine, University of Pécs, Pécs, Hungary. judit.d.nagy@aok.pte.hu
Journal of Crohn'S & Colitis
|December 3, 2010
Summary
Serum prohepcidin levels did not show significant differences in patients with inflammatory bowel diseases. Therefore, prohepcidin measurement is not a reliable indicator for diagnosing or predicting anemia in Crohn's disease or ulcerative colitis.
Area of Science:
- Gastroenterology
- Hematology
- Biochemistry
Background:
- Anemia is a common symptom in inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis.
- Anemia in IBD can result from blood loss, impaired iron absorption, or inflammation.
- The role of hepcidin, a key regulator of iron metabolism, in IBD-related anemia is not fully understood.
Purpose of the Study:
- To investigate the relationship between serum prohepcidin levels and clinical markers of iron homeostasis and inflammation in IBD patients.
- To determine if serum prohepcidin can serve as a diagnostic or prognostic tool for anemia in Crohn's disease and ulcerative colitis.
Main Methods:
- Serum prohepcidin levels were quantified using ELISA.
- The study included 72 patients with ulcerative colitis and 30 patients with Crohn's disease.
- Comparisons were made with healthy controls, and correlations with iron parameters and inflammatory markers were analyzed.
Main Results:
- Patients with IBD exhibited lower serum iron and higher C-reactive protein levels than controls.
- Serum prohepcidin levels were not significantly different between IBD patients and healthy controls.
- Weak correlations were found between prohepcidin and parameters like transferrin, iron-binding capacity, transferrin saturation, and albumin in Crohn's disease, and transferrin and transferrin saturation in ulcerative colitis.
Conclusions:
- Serum prohepcidin levels alone are insufficient for diagnosing or predicting anemia in inflammatory bowel diseases.
- Further research may be needed to fully elucidate the role of hepcidin in the pathogenesis of IBD-related anemia.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...